Azathioprine induced nodular regenerative hyperplasia in IBD patients
- 1 May 2005
- journal article
- case report
- Published by Elsevier in Gastroentérologie Clinique Et Biologique
- Vol. 29 (5) , 600-603
- https://doi.org/10.1016/s0399-8320(05)82136-0
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Tioguanine in patients with Crohn's disease intolerant or resistant to azathioprine/mercaptopurineAlimentary Pharmacology & Therapeutics, 2003
- 6-thioguanine can cause serious liver injury in inflammatory bowel disease patientsGastroenterology, 2003
- Thioguanine: A Potential Alternate Thiopurine for Ibd Patients Allergic To 6-Mercaptopurine Or AzathioprineAmerican Journal of Gastroenterology, 2003
- Biologic and Molecular Mechanisms for Sex Differences in Pharmacokinetics, Pharmacodynamics, and Pharmacogenetics: Part IJournal of Women's Health & Gender-Based Medicine, 2002
- The treatment of inflammatory bowel disease with 6‐mercaptopurine or azathioprineAlimentary Pharmacology & Therapeutics, 2001
- Portal hypertension in the presence of minimal liver damage in Crohnʼs disease on long-term azathioprine:European Journal of Gastroenterology & Hepatology, 2000
- Cholestatic Hepatocellular Injury with Azathioprine: A Case Report and Review of the Mechanisms of HepatotoxicityCanadian Journal of Gastroenterology and Hepatology, 1998
- Azathioprine induced fever, chills, rash, and hepatotoxicity in rheumatoid arthritis.Annals of the Rheumatic Diseases, 1990
- Diffuse nodular regenerative hyperplasia of the liver (DNRH). A clinicopathologic study of 24 casesLiver International, 1989
- Nodular transformation (nodular “Regenerative” hyperplasia) of the liverHuman Pathology, 1981